Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Once-a-day pill as switch option receives thumbs up across multiple HIV populations
Switching to the once-a-day, fixed-dose pill that contains bictegravir, emtricitabine, and tenofovir (BIC/FTC/TAF) appears to be safe and effective in older HIV patients and in people living with HIV (PLHIV) with pretreatment or treatment-acquired resistance, in addition to yielding metabolic benefits, according to studies presented at HIV Glasgow 2022.
Once-a-day pill as switch option receives thumbs up across multiple HIV populations
04 Nov 2022
Detectable viral loads persist in one-third of PLHIV in Asia-Pacific region
Between 2015 and 2020, nearly a third of people living with HIV (PLHIV) in Asia-Pacific countries still show a detectable viral load, according to a study presented at the HIV Glasgow 2022 Congress.
Detectable viral loads persist in one-third of PLHIV in Asia-Pacific region
04 Nov 2022
Extrapulmonary manifestations of telomere syndrome tied to shorter survival in IPF
Patients with idiopathic pulmonary fibrosis (IPF) who have extrapulmonary manifestations of a telomere syndrome show a decreased survival, according to a recent study.
Extrapulmonary manifestations of telomere syndrome tied to shorter survival in IPF
04 Nov 2022
Psychosis: Has perceived public stigma changed in Hong Kong?
Perceived public stigma (PPS) towards psychosis has remained static over 9 years in Hong Kong, with different education groups showing unique patterns of changes in PPS and endorsement of medication treatment across the years, researchers from the University of Hong Kong (HKU) have reported.
